Biofrontera Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz ® with the RhodoLED ® lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne.
No news available
Have a question or want to work together? Fill out the form below and we’ll get back to you as soon as possible.
